Cargando…

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency

Detalles Bibliográficos
Autores principales:	Parsons, MS, Zanoni, P, Tallon, B, Miconiatis, S, Shoukry, N, Bruneau, J, Tsoukas, CM, Bernard, NF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441962/ http://dx.doi.org/10.1186/1742-4690-9-S2-P187

Ejemplares similares

Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure?
por: Tallon, B, et al.
Publicado: (2012)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

Time to Seroconversion in HIV-Exposed Subjects Carrying Protective versus Non Protective KIR3DS1/L1 and HLA-B Genotypes
por: Tallon, Benjamin J. M., et al.
Publicado: (2014)

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
por: Ehlers, Femke A. I., et al.
Publicado: (2021)

HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness
por: Jackson, Elise, et al.
Publicado: (2017)

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
por: Tang, Jennifer J.-J., et al.
Publicado: (2020)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

The Roles of Uterine Natural Killer (NK) Cells and KIR/HLA-C Combination in the Development of Preeclampsia: A Systematic Review
por: Yang, Xiuhua, et al.
Publicado: (2020)

ADCC potency assay: increased standardization with modified lymphocytes
por: Bretaudeau, Laurent, et al.
Publicado: (2011)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
por: Thobakgale, CF, et al.
Publicado: (2012)

Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation
por: Nowak, Izabela, et al.
Publicado: (2012)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
por: Tuttolomondo, Antonino, et al.
Publicado: (2019)

HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets
por: Song, Rujun, et al.
Publicado: (2014)

KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease
por: Levinson, Ralph D., et al.
Publicado: (2016)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Khanna, Vidhi, et al.
Publicado: (2021)

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells
por: Simhadri, Venkateswara R., et al.
Publicado: (2015)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

Genotypic diversity of the Killer Cell Immunoglobulin-like Receptors (KIR) and their HLA class I Ligands in a Saudi population
por: Omar, Suliman Y. Al, et al.
Publicado: (2016)

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
por: Decaup, Emilie, et al.
Publicado: (2019)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
por: Guo, Jing-Jie, et al.
Publicado: (2022)

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
por: Yawata, Makoto, et al.
Publicado: (2006)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
por: Cardozo, Daniela Maira, et al.
Publicado: (2023)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
por: Carlomagno, Simona, et al.
Publicado: (2017)

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
por: Pende, Daniela, et al.
Publicado: (2019)

Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C
por: Vollmers, Sarah, et al.
Publicado: (2022)

Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires
por: Philippon, Camille, et al.
Publicado: (2023)

Characterization of KIR (+) NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C
por: Meazza, Raffaella, et al.
Publicado: (2022)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs
por: Ichise, Hiroshi, et al.
Publicado: (2017)

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
por: Varbanova, Viktoria Plamenova, et al.
Publicado: (2019)

“Universal Flu Vaccine”: Can NK Cell-mediated ADCC Tip the Scales?
por: Hassane, Maya, et al.
Publicado: (2016)

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2009)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population
por: Nakimuli, Annettee, et al.
Publicado: (2013)

Natural Killer cells present in gut mucosa as potential ADCC effector cells
por: Sips, M, et al.
Publicado: (2012)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients
por: Dubreuil, Léa, et al.
Publicado: (2021)

Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
por: Alter, Galit, et al.
Publicado: (2007)

Erratum to: Distribution of killer cell immunoglobulin-like receptors(KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2010)

Impact of multiplicity of functional KIR-HLA compound genotypes on hepatocellular carcinoma
por: Tanimine, Naoki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9104f3c1qemajrq8qdusbdrtec